aXichem AB Total Liabilities

Latest as of September 2025: Skr9.69 Million SEK ≈ $1.04 Million USD

aXichem AB total liabilities. Based on the latest financial reports, aXichem AB (AXIC-A) has total liabilities worth Skr9.69 Million SEK (≈ $1.04 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how many days can aXichem AB fund operations to measure how many days the company can operate on defensive assets alone.

Total Liabilities of aXichem AB (2008–2024)

Total liabilities of aXichem AB from 2008 to 2024. This chart illustrates how aXichem AB's total liabilities have evolved over time, based on quarterly financial data.

aXichem AB Competitors by Total Liabilities

The table below lists competitors of aXichem AB ranked by their total liabilities.

Company Country Total Liabilities
InnoTherapy Inc
KQ:246960
Korea ₩50.78 Billion
Schroder Oriental Income Fund
LSE:SOI
UK GBX44.42 Million
Pure Resources Ltd
AU:PR1
Australia AU$476.80K
Chuan Huat Resources Bhd
KLSE:7016
Malaysia RM319.65 Million
Kingfish Company Nv
OL:KING
Norway Nkr122.14 Million
Netlinkz Ltd
AU:NET
Australia AU$28.13 Million
Active Biotech AB
ST:ACTI
Sweden Skr10.70 Million
NPK Co.Ltd
KQ:048830
Korea ₩23.33 Billion

Liability Composition Analysis (2008–2024)

This chart breaks down aXichem AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see aXichem AB balance sheet assets.

Liquidity & Leverage Metrics

aXichem AB Total Liabilities Ratios Explained

aXichem AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.17 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how aXichem AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for aXichem AB (2008–2024)

The table below shows the annual total liabilities of aXichem AB from 2008 to 2024.

Year Total Liabilities Change
2024-12-31 Skr4.12 Million
≈ $443.92K
-68.18%
2023-12-31 Skr12.96 Million
≈ $1.40 Million
-38.05%
2022-12-31 Skr20.92 Million
≈ $2.25 Million
+745.76%
2021-12-31 Skr2.47 Million
≈ $266.24K
+17.92%
2020-12-31 Skr2.10 Million
≈ $225.78K
+15.34%
2019-12-31 Skr1.82 Million
≈ $195.75K
-80.53%
2018-12-31 Skr9.34 Million
≈ $1.01 Million
+98.77%
2017-12-31 Skr4.70 Million
≈ $505.80K
-17.24%
2016-12-31 Skr5.68 Million
≈ $611.15K
+23.35%
2015-12-31 Skr4.60 Million
≈ $495.46K
-28.52%
2014-12-31 Skr6.44 Million
≈ $693.15K
-54.66%
2013-12-31 Skr14.21 Million
≈ $1.53 Million
+52.02%
2012-12-31 Skr9.34 Million
≈ $1.01 Million
-30.15%
2011-12-31 Skr13.38 Million
≈ $1.44 Million
+16.71%
2010-12-31 Skr11.46 Million
≈ $1.23 Million
+50.42%
2009-12-31 Skr7.62 Million
≈ $820.11K
-10.31%
2008-12-31 Skr8.50 Million
≈ $914.36K
--

About aXichem AB

ST:AXIC-A Sweden Specialty Chemicals
Market Cap
$11.64 Million
Skr108.18 Million SEK
Market Cap Rank
#26524 Global
#556 in Sweden
Share Price
Skr1.83
Change (1 day)
-4.69%
52-Week Range
Skr1.17 - Skr3.70
All Time High
Skr91.49
About

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings a… Read more